ME/NaPhos/MB/Hyo1 and Sarilumab Subcutaneous
Determining the interaction of ME/NaPhos/MB/Hyo1 and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- ME/NaPhos/MB/Hyo1-Sarna Hc Topical application
- ME/NaPhos/MB/Hyo1-Sarnol-HC
- ME/NaPhos/MB/Hyo1-Sarnol-HC Maximum Strength
- ME/NaPhos/MB/Hyo1-SAStid
- ME/NaPhos/MB/Hyo1-Sastid Soap Topical
- ME/NaPhos/MB/Hyo1-SAStid Topical
- Sarilumab Subcutaneous-Measles and rubella virus vaccine live Intramuscular, Injection
- Sarilumab Subcutaneous-Measles virus vaccine, live Subcutaneous
- Sarilumab Subcutaneous-Measles, mumps, and rubella (MMR) vaccine
- Sarilumab Subcutaneous-Measles, Mumps, and Rubella Vaccine
- Sarilumab Subcutaneous-Measles, Mumps, and Rubella Virus Vaccine
- Sarilumab Subcutaneous-Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular